Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness

To determine whether the early serologic response in COVID-19 critical illness is associated with hospital mortality. To evaluate if time-to-seroconversion differs by receipt of dexamethasone therapy. DESIGN: Patients were prospectively enrolled within 24 hours of ICU admission from two University o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabrey, F. Linzee, Zelnick, Leila R., Morrell, Eric D., O’Connor, Nicholas G., Hart, Andrew, Wurfel, Mark M., Liles, W. Conrad, Bhatraju, Pavan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426803/
https://www.ncbi.nlm.nih.gov/pubmed/36050993
http://dx.doi.org/10.1097/CCE.0000000000000754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426803/
https://www.ncbi.nlm.nih.gov/pubmed/36050993
http://dx.doi.org/10.1097/CCE.0000000000000754

Ejemplares similares